B. Molloy

Rapid determination of the pharmacokinetics and metabolic fate of gefitinib in the mouse using a combination of UPLC/MS/MS, UPLC/QToF/MS, and ion mobility (IM)-enabled UPLC/QToF/MS

I. Wilson, R. Plumb, L. Gethings, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

A hydrodynamic approach to the measurement of the permeability of small molecules across artificial membranes.

R. Dryfe, K. Tam, B. Molloy, 2008, The Analyst.

The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC–IM–MS Study

I. Wilson, R. Plumb, L. Gethings, 2021, Metabolites.

Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25‐(OH)2D3 in Affected Patients

D. Cooper, J. Gallagher, Glenville Jones, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity-associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometry.

R. Wevers, C. Tack, R. Stienstra, 2020, Prostaglandins, leukotrienes, and essential fatty acids.